Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Technetium-99m-labelled colchicine complex, preparation method thereof and purpose thereof

A technology of -99m, colchicine, applied in the field of radiopharmaceutical preparation and application, can solve the problem of no drug activity, etc., and achieve the effects of good water solubility, good tumor/muscle ratio, good tumor uptake and retention

Active Publication Date: 2016-06-01
INST OF HIGH ENERGY PHYSICS CHINESE ACAD OF SCI
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the ligands in the above-mentioned technetium complexes have no corresponding drug activity, and the targeting needs to be improved.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Technetium-99m-labelled colchicine complex, preparation method thereof and purpose thereof
  • Technetium-99m-labelled colchicine complex, preparation method thereof and purpose thereof
  • Technetium-99m-labelled colchicine complex, preparation method thereof and purpose thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0029] (1) Synthesis of DTPA-CHC ligand

[0030] Dissolve DTPA anhydride (35.7mg, 0.1mmol) and trimethylcolchicinic acid (34.3mg, 0.1mmol) in 1mL DMF, then add 20μL DIPEA, stir at room temperature for 1h; add 1mL water, shake well, filter, and the filtrate is purified by HPLC . HPLC purification method: Kromasil100-5C18 purification column (100 * 250mm), mobile phase is to contain 0.1% TFA (trifluoroacetic acid) water (A phase) and contain 0.1% TFA methanol (B phase), flow velocity 3mL / min; t= 0, A / B=6.5 / 3.5; t=15min, A / B=1 / 9; t=20min, A / B=1 / 9; t=25min, A / B=6.5 / 3.5. The fraction with a retention time of 11.35 min was collected and freeze-dried to obtain DTPA-CHC (48.1 mg, 67.0%) as a white powdery solid. ESI-MS: 719.26 (MH + ), 741.25 (M+Na + ).

[0031] Preparation of technetium-99m-labeled colchicine complex: Dissolve 1 mg DTPA-CHC ligand in 0.5 mL water, add 50 μL SnCl 2 Solution (1mg / mL, pH=1) and 0.1mL freshly rinsed sodium pertechnetate solution (3mCi), then add 0....

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a technetium-99m-labelled colchicine complex, a preparation method thereof and a purpose thereof. The preparation method is characterized in that trimethyl colchicum acid and DTPA acid anhydride are subjected to coupling and hydrolysis to obtain a novel ligand DTPA-CHC, the ligand is subjected to <99m>Tc direct labeling under reducing action of stannous to obtain the technetium-99m-labelled colchicine complex, complex radiochemical purity is greater than 90%, the complex exists at room temperature for more than 6 h in a stable mode, and lipid-water partition coefficients determination shows that <99m>Tc-DTPA-CHC is a water-soluble compound. The technetium-99m-labelled colchicine complex has good tumor ingestion and detention effects, tumor / muscle ratio is high, tumor imaging is clear, and the technetium-99m-labelled colchicine complex can be used for SPECT imaging diagnosis for tumor.

Description

technical field [0001] The present invention relates to a compound labeled with radionuclide, and a preparation method and application of the compound, in particular to a technetium-99m-labeled colchicine complex, which belongs to the field of radiopharmaceutical preparation and application. Background technique [0002] Malignant tumor is one of the main diseases that lead to abnormal death of human beings. It has become the second cause of human death, second only to cardiovascular and cerebrovascular diseases, and has risen to the first place in some places, posing a huge threat to human beings. One of the most difficult diseases to deal with. [0003] Early diagnosis and treatment of cancer are crucial to improving the cure rate and quality of life of patients. The most important application value of radiopharmaceuticals is the study of physiological and chemical changes in the life process; PET or SPECT imaging using radionuclide-labeled biological functional molecules...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C233/32C07C231/02A61K51/04A61K103/10
Inventor 汪建军刘宇杨文江张延华薛井泉
Owner INST OF HIGH ENERGY PHYSICS CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com